One of the most widely proposed pathways in the progression of NAFLD and hepatic fibrosis is the metabolic or insulin signaling pathway, which is associated with insulin resistance/hyperinsulinemia and hyperglycemia (Figure 2). The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.